Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYPTAM study of CYP2D6, endoxifen, and tamoxifen response in adjuvant breast cancer
NL-OMON23389Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tamoxifen in breast cancer, sponsored by Leiden University Medical Center. Started Feb 2008; status: active, not recruiting.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON23389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23389.